Vizoptik drops Ch. 0.05% 15ml vial, cap.

Description

Composition
Active substance:
1 ml contains: tetryzoline hydrochloride – 0.50 mg ;.
Excipients:
Boric acid – 18.50 mg, Sodium tetraborate decahydrate – 0.65 mg disodium edetatadigidrat – 1.00 mg benzalkonium chloride 0.10 mg Purified water – up to 1.0 ml.
Description:
The clear, colorless solution.
Product form:
Eye drops 0.05%. 15 ml of the polymer solution in white-dropper bottle closed with a polymeric cap with a safety ring. In one flakonu- drip chamber together with instructions for use in a cardboard package.
Contraindications
Hypersensitivity to the drug; closure glaucoma; Children under 2 years
Carefully
In patients with severe cardiovascular disease (coronary heart disease, hypertension, aneurysm); pheochromocytoma; prostatic hyperplasia; hyperthyroidism; diabetes; porphyria; dry rhinitis; dry eye; glaucoma; in patients treated with inhibitors of monoamine oxidase (MAO) or other medicines capable of improving blood pressure; in elderly patients; during pregnancy and lactation.
Dosage
0.5 mg / ml
Indications
For removal of edema and conjunctival hyperemia (eye redness) due to the influence of chemical and physical factors (smoke, wind, dust, chlorinated water, light, cosmetics, contact lenses), and the resulting allergic reactions such as hay fever.
Interaction with other drugs
The drug should not be used simultaneously with MAO type tranylcypromine inhibitors, tricyclic antidepressants, and drugs that increase blood pressure. The combined use of these groups of drugs can lead to increased vasoconstrictive effect and blood pressure. If you apply the above or other medications (including over the counter) before using VizOptik drug, you consult your physician.
Overdose
When used in accordance with the instructions the risk of overdose is minimal. However, if accidentally released into the gastrointestinal tract (ingestion), the following symptoms of overdose: mydriasis, nausea, cyanosis, fever, convulsions, tachycardia, arrhythmia, heart failure, hypertension, pulmonary edema, inhibition of respiratory function (including respiratory arrest) depression of the central nervous system (including the development of drowsiness and to whom). The risk of developing symptoms of overdose due to systemic effects of the drug, is high in infants and young children, especially if swallowed. A specific antidote is not known. Treatment of overdose by ingestion into the gastrointestinal tract: activated charcoal, gastric lavage, inhalation of oxygen, antipyretic and anti-seizure drugs. To reduce arterial pressure is applied 5 mg phentolamine in saline slowly intravenously or 100 mg orally. Patients with low blood pressure pressor agents are contraindicated. When any signs of overdose, as described above, you should immediately consult a doctor !.
pharmachologic effect
Pharmacological group:
Alpha – adrenoagonists.
Pharmacodynamics:
Tetryzoline – Adrenomimeticalkie drug that stimulates alpha-adrenergic receptors of the sympathetic nervous system, but it does not have or has little effect on the beta-adrenergic receptors. As adrenomimeticheskim amine tetryzoline has vasoconstrictor activity and reduces tissue edema. The effect begins 60 seconds after instillation and lasts 4-8 hours.
Pharmacokinetics:
The local application is possible systemic absorption in patients with lesions of the mucosa and epithelium. Detailed pharmacokinetic studies after topical application were not conducted eye drops.
Pregnancy and breast-feeding
Data on penetration of the drug through the placenta and breast milk are not available. Given the risk of systemic reactions, use the drug during pregnancy and lactation is possible only in the case if, but the opinion of the physician, the expected benefit to the mother outweighs the potential risk to the fetus and child. Before applying VizOptik medication if you are pregnant or suspect that you might be pregnant, or planning to become pregnant, you must consult your doctor. During the period of breast-feeding before using VizOptik drug should consult a doctor.
Conditions of supply of pharmacies
Without a prescription.
side effects
Post-marketing data
Adverse reactions are classified according to frequency of occurrence of the following gradation: very often (> 1/10), often (> 1/100
special instructions
The drug should be used with caution in elderly patients; in patients with aneurysms, arterial hypertension and / or coronary heart disease, pheochromocytoma, prostatic hyperplasia, porphyria, dry rhinitis; dry keratokonyonktivitom; glaucoma; patients receiving MAO inhibitors or other drugs that can increase blood pressure; as well as in patients with diabetes or hyperthyroidism. Use of the drug in angle-closure glaucoma is contraindicated. In other types of glaucoma medication used with extreme caution and under medical supervision. Security research and adolescents have not been conducted in children. Contact lenses should be removed before instillation of the drug and re-install them after 15 minutes. It is necessary to avoid direct contact of the product with soft contact lenses due to a possible violation of their transparency. Perhaps the development of reactive hyperemia of the conjunctiva and mucous membranes of the nose (rhinitis medicamentosa) for not respecting the instructions for use. If within 72 hours does not improve or irritation and hyperemia persist or grow, it is necessary to cancel the use of the drug and seek medical advice. When the intense pain in the eyes, severe acute unilateral or red eyes, headaches, blurred vision, the appearance of spots before the eyes or double vision, immediately consult a doctor. Long term use of the drug can enhance or cause flushing its reappearance. If irritation or redness of the body caused by disease: infection, a foreign body or chemical corneal injury, before using consult your doctor. Use of the drug can cause temporary expansion of the pupil. Avoid prolonged use and drug overdoses, particularly in children.
You can not use in patients with a change in its color or turbidity. Topical application of sympathomimetic amines in the conjunctival sac, resulting in expansion of the pupils may sometimes lead to a violation of intraocular pressure in predisposed individuals. If the drug has come into disrepair or expiration date – do not pour it into the waste water and not be thrown into the street! Put it in the bag and place in the trash. These measures will help protect the environment!
Effect on the ability to drive mechanisms and
In rare cases, after treatment there blurred vision, which may affect the ability to drive and use machines.
Storage conditions
Store at a temperature not higher than 25 ° C, in the original package.
Keep out of the reach of children.
Dosing and Administration
Locally.
Adults and children over 2 years: 1 drop in the affected eye 2-3 times a day. Use of the drug for more than 4 days should be taken only under medical supervision.
Use according to the drug only indications that the application and in those doses which are specified in the instruction.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist